Seeking Alpha

Salix Pharmaceuticals (SLXP +0.2%) says it's submitted a New Drug Application to the FDA for its...

Salix Pharmaceuticals (SLXP +0.2%) says it's submitted a New Drug Application to the FDA for its HIV-induced diarrhea drug Crofelemer. The agency has 60 days to review the application and decide whether it will enter its review process. The drug developer is also researching alternative possible uses for the drug, including the treatment of irritable bowel syndrome.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs